# url

id: amwa-118
domain: info.amwa.org
url:
  https://info.amwa.org/hubfs/offers/regulatory-writer-training%20ebook/regulatory-writer-training.pdf


id: amwa-88
domain: www.fda.gov
url:
  https://www.fda.gov/about-fda/center-drug-evaluationand-research-cder/office-prescription-drug-promotion-opdp


id: amwa-88
domain: www.fda.gov
url:
  https://www.fda.gov/about-fda/center-drug-evaluation-and-research-cder/office-prescription-drug-promotion-opdp


id: amwa-91
domain: www.themuse.com
url:
  https://www.themuse.com/advice/allstarlinkedin-users-are-40-times-more-likely-to-get-contactedheres-how-toscore-that-rating


id: amwa-91
domain: www.themuse.com
url:
  https://www.themuse.com/advice/allstar-linkedin-users-are-40-times-more-likely-to-get-contactedheres-how-to-score-that-rating


id: amwa-20
domain: www.windowscentral.com
url:
  https://www.windowscentral.com/thereare-now-12-billion-office-users-60-million-office-365-commercialcustomers


id: amwa-20
domain: www.windowscentral.com
url:
  https://www.windowscentral.com/there-are-now-12-billion-office-users-60-million-office-365-commercial-customers


id: amwa-92
domain: www.jimcollins.com
url:
  https://www.jimcollins.com/article_topics/articles/hedgehog-concept-business-sectors.html#articletop


id: amwa-155
domain: www.wma.net
url:
  https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects


id: amwa-101
domain: www.fiercebiotech.com
url:
  https://www.fiercebiotech.com/biotech/2022talent-war-life-sciences-salary-inflation-c-suite-builds-tonegative-feedback-loop


id: amwa-101
domain: www.fiercebiotech.com
url:
  https://www.fiercebiotech.com/biotech/2022-talent-war-life-sciences-salary-inflation-c-suite-builds-to-negative-feedback-loop


id: amwa-101
domain: www.massbioed.org
url:
  https://www.massbioed.org/wp-content/uploads/2021/08/2021-life-sciences-workforce-conference-breakout-group-summary.pdf


id: amwa-93
domain: www.ftc.gov
url:
  https://www.ftc.gov/news-events/press-releases/2019/04/court-rules-ftcs-favor-against-predatory-academic-publisher-omics


id: amwa-125
domain: shop.lww.com
url:
  https://shop.lww.com/stedman-s-plus-2022medical-pharmaceutical-spellchecker--single-userdownload-/p/9781975183677


id: amwa-125
domain: shop.lww.com
url:
  https://shop.lww.com/stedman-s-plus-2022-medical-pharmaceutical-spellchecker--single-user-download-/p/9781975183677


id: amwa-142
domain: www.who.int
url:
  https://www.who.int/emergencies/diseases/novel-coronavirus-2019/global-research-on-novel-coronavirus-2019-ncov/solidarity-clinical-trial-for-covid-19-treatments


id: amwa-142
domain: www.newsweek.com
url:
  https://www.newsweek.com/2017/04/14/prescription-drug-pricing-569444.html#:~:text=reimbursement%20is%20the%20amount%20the,as%20a%20pharmacy%20benefit%20manager


id: amwa-13
domain: newsroom.heart.org
url:
  https://newsroom.heart.org/news/patients-taking-acei-and-arbs-who-contract-covid-19-should-continue-treatment-unlessotherwise-advised-by-their-physician


id: amwa-13
domain: www.who.int
url:
  https://www.who.int/news/item/0407-2020-who-discontinues-hydroxychloroquine-and-lopinavirritonavir-treatment-arms-for-covid-19


id: amwa-13
domain: www.who.int
url:
  https://www.who.int/data/gho/data/indicators/indicator-details/gho/raised-blood-pressure-(sbp-=140-or-dbp-=90)-(age-standardized-estimate


id: amwa-13
domain: www.heart.org
url:
  https://www.heart.org/en/news/2020/05/18/is-high-blood-pressure-inevitable-heres-how-to-keep-it-in-check


id: amwa-13
domain: www.cdc.gov
url:
  https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/people-with-medical-conditions.html


id: amwa-13
domain: newsroom.heart.org
url:
  https://newsroom.heart.org/news/patients-taking-ace-i-and-arbs-who-contract-covid-19-should-continue-treatment-unless-otherwise-advised-by-their-physician


id: amwa-13
domain: clinicaltrials.gov
url:
  https://clinicaltrials.gov/ct2/results?cond=covid19&term=ace%2c+arb&type=&rslt=&recrs=a&recrs=f&recrs=d&age_v=&gndr=&intr=&titles=&outc=&spons=&lead=&id=&cntry=&state=&city=&dist=&locn=&rsub=&strd_s=&strd_e=&prcd_s=&prcd_e=&sfpd_s=&sfpd_e=&rfpd_s=&rfpd_e=&lupd_s=&lupd_e=&sort


id: amwa-13
domain: www.who.int
url:
  https://www.who.int/news/item/04-07-2020-who-discontinues-hydroxychloroquine-and-lopinavir-ritonavir-treatment-arms-for-covid-19


id: amwa-13
domain: www.who.int
url:
  www.who.int/emergencies/diseases/novel-coronavirus-2019/technicalguidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virusthat-causes-it


id: amwa-13
domain: www.fda.gov
url:
  https://www.fda.gov/emergencypreparedness-and-response/coronavirus-disease-2019-covid-19/pfizerbiontech-covid-19-vaccine


id: amwa-13
domain: www.covid19treatmentguidelines.nih.gov
url:
  https://www.covid19treatmentguidelines.nih.gov/antiviral-therapy/chloroquine-or-hydroxychloroquine-with-or-without-azithromycin


id: amwa-13
domain: www.covid19treatmentguidelines.nih.gov
url:
  https://www.covid19treatmentguidelines.nih.gov/antiviral-therapy/lopinavir-ritonavir-and-other-hiv-protease-inhibitors


id: amwa-13
domain: www.who.int
url:
  https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-diseasehttps://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-diseasehttps://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it


id: amwa-13
domain: www.fda.gov
url:
  https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/pfizer-biontech-covid-19-vaccine


id: amwa-13
domain: www.fda.gov
url:
  https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/moderna-covid-19-vaccine


id: amwa-82
domain: static-content.springer.com
url:
  https://static-content.springer.com/esm/art%3a10.1177%2f2168479017721585/mediaobjects/43441_2018_5201070_moesm2_esm.pdf


id: amwa-82
domain: cdn.ymaws.com
url:
  https://cdn.ymaws.com/www.amwa.org/resource/resmgr/certification/forms/2018/mwcstudyguideresourcelist.pdf


id: amwa-82
domain: www.pharmaceuticalonline.com
url:
  https://www.pharmaceuticalonline.com/doc/skillsan-exceptional-project-manager-can-t-survive-without-0001


id: amwa-82
domain: www.forbes.com
url:
  https://www.forbes.com/sites/brentgleeson/2013/10/02/the-silo-mentality-how-to-break-down-the-barriers


id: amwa-82
domain: globalforum.diaglobal.org
url:
  https://globalforum.diaglobal.org/issue/may-2020/medical-writing-the-language-and-art-of-scientific-communication


id: amwa-82
domain: edservices.wiley.com
url:
  https://edservices.wiley.com/wp-content/uploads/2021/02/202102-reimaginingtheworkforce2021-report-wes.pdf


id: amwa-82
domain: static-content.springer.com
url:
  https://static-content.springer.com/esm/art%3a10.1177%2f2168479017721585/mediaobjects/43441_2018_5201070_moesm1_esm.pdf


id: amwa-82
domain: www.pharmaceuticalonline.com
url:
  https://www.pharmaceuticalonline.com/doc/skills-an-exceptional-project-manager-can-t-survive-without-0001


id: amwa-168
domain: www.petersons.com
url:
  https://www.petersons.com/graduateschools/university-of-the-sciences-in-philadelphia-college-ofgraduate-studies-program-in-biomedical-writing-000_10039831


id: amwa-48
domain: www.reuters.com
url:
  https://www.reuters.com/article/us-health-coronavirus-facebook/on-facebook-health-misinformation-superspreaders-rack-up-billions-of-views-report-iduskcn25f1m4


id: amwa-17
domain: www.who.int
url:
  https://www.who.int/news-room/fact-sheets/detail/middle-eastrespiratory-syndrome-coronavirus-(mers-cov


id: amwa-17
domain: www.who.int
url:
  https://www.who.int/news-room/fact-sheets/detail/middle-east-respiratory-syndrome-coronavirushttps://www.who.int/news-room/fact-sheets/detail/middle-east-respiratory-syndrome-coronavirus-(mers-cov


id: amwa-17
domain: www.the-scientist.com
url:
  https://www.the-scientist.com/bio-business/how-the-pharmaindustry-pulled-off-the-pivot-to-covid-19-67719


id: amwa-17
domain: www.fda.gov
url:
  https://www.fda.gov/news-events/press-announcements/fdaannounces-key-actions-advance-development-novel-coronavirusmedical-countermeasures


id: amwa-17
domain: www.fda.gov
url:
  https://www.fda.gov/regulatory-information/search-fdaguidance-documents/emergency-use-authorization-medical-productsand-related-authorities


id: amwa-17
domain: www.fda.gov
url:
  https://www.fda.gov/news-events/pressannouncements/fda-takes-significant-step-coronavirus-responseefforts-issues-emergency-use-authorization-first


id: amwa-17
domain: www.fda.gov
url:
  https://www.fda.gov/regulatoryinformation/search-fda-guidance-documents/policy-coronavirusdisease-2019-tests-during-public-health-emergency-revised


id: amwa-17
domain: www.fda.gov
url:
  https://www.fda.gov/news-events/pressannouncements/coronavirus-covid-19-update-fda-takes-new-actionsaccelerate-development-novel-prevention-treatment


id: amwa-17
domain: www.fda.gov
url:
  https://www.fda.gov/regulatory-information/search-fda-guidancedocuments/covid-19-public-health-emergency-general-considerationspre-ind-meeting-requests-covid-19-related


id: amwa-17
domain: www.fda.gov
url:
  https://www.fda.gov/regulatory-information/search-fda-guidancedocuments/statistical-considerations-clinical-trials-during-covid-19public-health-emergency-guidance-industry


id: amwa-17
domain: www.fda.gov
url:
  https://www.fda.gov/regulatoryinformation/search-fda-guidance-documents/development-andlicensure-vaccines-prevent-covid-19


id: amwa-17
domain: www.who.int
url:
  www.who.int/emergencies/diseases/novel-coronavirus-2019/globalresearch-on-novel-coronavirus-2019-ncov/solidarity-clinical-trial-forcovid-19-treatments


id: amwa-17
domain: www.fda.gov
url:
  https://www.fda.gov/regulatory-information/searchfda-guidance-documents/assessing-covid-19-related-symptomsoutpatient-adult-and-adolescent-subjects-clinical-trials-drugs


id: amwa-17
domain: www.the-scientist.com
url:
  https://www.the-scientist.com/bio-business/how-the-pharma-industry-pulled-off-the-pivot-to-covid-19-67719


id: amwa-17
domain: www.who.int
url:
  https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020


id: amwa-17
domain: www.fda.gov
url:
  https://www.fda.gov/news-events/press-announcements/fda-announces-key-actions-advance-development-novel-coronavirus-medical-countermeasures


id: amwa-17
domain: www.fda.gov
url:
  https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/emergency-use-authorization


id: amwa-17
domain: www.fda.gov
url:
  https://www.fda.gov/regulatory-information/search-fda-guidance-documents/emergency-use-authorization-medical-products-and-related-authorities


id: amwa-17
domain: www.fda.gov
url:
  https://www.fda.gov/news-events/press-announcements/fda-takes-significant-step-coronavirus-response-efforts-issues-emergency-use-authorization-first


id: amwa-17
domain: www.fda.gov
url:
  https://www.fda.gov/regulatory-information/search-fda-guidance-documents/policy-coronavirus-disease-2019-tests-during-public-health-emergency-revised


id: amwa-17
domain: www.fda.gov
url:
  https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-takes-new-actions-accelerate-development-novel-prevention-treatment


id: amwa-17
domain: www.fda.gov
url:
  https://www.fda.gov/regulatory-information/search-fda-guidance-documents/covid-19-public-health-emergency-general-considerations-pre-ind-meeting-requests-covid-19-related


id: amwa-17
domain: www.fda.gov
url:
  https://www.fda.gov/regulatory-information/search-fda-guidance-documents/covid-19-developing-drugs-and-biological-products-treatment-or-prevention


id: amwa-17
domain: www.fda.gov
url:
  https://www.fda.gov/regulatory-information/search-fda-guidance-documents/statistical-considerations-clinical-trials-during-covid-19-public-health-emergency-guidance-industry


id: amwa-17
domain: www.fda.gov
url:
  https://www.fda.gov/regulatory-information/search-fda-guidance-documents/development-and-licensure-vaccines-prevent-covid-19


id: amwa-17
domain: www.europeanpharmaceuticalreview.com
url:
  https://www.europeanpharmaceuticalreview.com/news/128134/impact-of-covid-19-on-clinical-trials-continuing-say-researchers


id: amwa-17
domain: www.fda.gov
url:
  https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-issues-guidance-conducting-clinical-trials


id: amwa-17
domain: www.fda.gov
url:
  https://www.fda.gov/regulatory-information/search-fda-guidance-documents/assessing-covid-19-related-symptoms-outpatient-adult-and-adolescent-subjects-clinical-trials-drugs


id: amwa-17
domain: www.who.int
url:
  https://www.who.int/news/item/0312-2020-global-access-to-covid-19-vaccines-estimated-to-generateeconomic-benefits-of-at-least-153-billion-in-2020-21


id: amwa-17
domain: www.who.int
url:
  https://www.who.int/news/item/31-12-2020-who-issues-its-firstemergency-use-validation-for-a-covid-19-vaccine-and-emphasizesneed-for-equitable-global-access


id: amwa-17
domain: www.fda.gov
url:
  https://www.fda.gov/news-events/pressannouncements/coronavirus-covid-19-update-fda-authorizes-firstdiagnostic-test-screening-people-without-known-or


id: amwa-17
domain: www.who.int
url:
  https://www.who.int/news/item/03-12-2020-global-access-to-covid-19-vaccines-estimated-to-generate-economic-benefits-of-at-least-153-billion-in-2020-21


id: amwa-17
domain: www.who.int
url:
  https://www.who.int/news/item/31-12-2020-who-issues-its-first-emergency-use-validation-for-a-covid-19-vaccine-and-emphasizes-need-for-equitable-global-access


id: amwa-17
domain: www.who.int
url:
  https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/early-investigations


id: amwa-17
domain: health.mo.gov
url:
  https://health.mo.gov/living/healthcondiseases/communicable/novel-coronavirus-lpha/pdf/fact-sheet-operation-warp-speed.pdf


id: amwa-17
domain: www.nih.gov
url:
  https://www.nih.gov/news-events/news-releases/nih-launch-public-private-partnership-speed-covid-19-vaccine-treatment-options


id: amwa-17
domain: www.nih.gov
url:
  https://www.nih.gov/news-events/news-releases/nih-launches-clinical-trials-network-test-covid-19-vaccines-other-prevention-tools


id: amwa-17
domain: www.fda.gov
url:
  https://www.fda.gov/drugs/coronavirus-covid-19-drugs/coronavirus-treatment-acceleration-program-ctap


id: amwa-17
domain: www.fda.gov
url:
  https://www.fda.gov/emergency-preparedness-and-response/counterterrorism-and-emerging-threats/coronavirus-disease-2019-covid-19


id: amwa-17
domain: www.fda.gov
url:
  https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-first-diagnostic-test-screening-people-without-known-or


id: amwa-14
domain: journal.emwa.org
url:
  http://journal.emwa.org/writing-better/amwa-emwa-ismpp-joint-position-statement-on-the-role-of-professional-medical-writers


id: amwa-14
domain: authorservices.wiley.com
url:
  https://authorservices.wiley.com/author-resources/journal-authors/prepare/free-format-submission.html


id: amwa-95
domain: jamanetwork.com
url:
  https://jamanetwork.com/journals/jamaoncology/article-abstract/2783530?guestaccesskey=e38e72e5-1cde-42ac-a66e-f0495987b788


id: amwa-43
domain: medium.com
url:
  https://medium.com/sutherland-labs/patient-experience-design-agame-changer-for-healthcare-31351623e010


id: amwa-43
domain: uxplanet.org
url:
  https://uxplanet.org/user-research-bias-how-it-hurts-your-appand-what-you-can-do-about-it-4433d295229c


id: amwa-43
domain: medium.com
url:
  https://medium.com/sutherland-labs/patient-experience-design-a-game-changer-for-healthcare-31351623e010


id: amwa-43
domain: ww2.frost.com
url:
  https://ww2.frost.com/news/press-releases/telehealth-to-experience-massive-growth-with-covid-19-pandemic-says-frost-sullivan


id: amwa-43
domain: uxplanet.org
url:
  https://uxplanet.org/user-research-bias-how-it-hurts-your-app-and-what-you-can-do-about-it-4433d295229c


id: amwa-171
domain: www.eeoc.gov
url:
  https://www.eeoc.gov/laws/guidance/enforcement-guidance-preemployment-disability-related-questions-and-medical#self-identify


id: amwa-171
domain: www.shrm.org
url:
  https://www.shrm.org/resourcesandtools/hr-topics/talent-acquisition/documents/employing_people_with_disabilities_toolkit_february_3_2015_v4.pdf


id: amwa-171
domain: blog.amwa.org
url:
  https://blog.amwa.org/equity-inclusion-tips#:~:text=in%20her%20amwa%20webinar%2c%20writing,differences%2c%20and%20promotes%20equal%20opportunities


id: amwa-171
domain: disabilityin.org
url:
  https://disabilityin.org/resource/six-tips-to-keep-in-mind-when-creating-accessible-virtual-meetings


id: amwa-171
domain: www.fastcompany.com
url:
  www.fastcompany.com/90750720/3-disabled-workers-share-howreturning-to-normal-makes-work-inaccessible?partner=rss&utm_


id: amwa-171
domain: www.cnet.com
url:
  https://www.cnet.com/tech/mobile/theoriginal-voice-of-siri-is-now-advocating-for-a-more-accessibleweb


id: amwa-171
domain: www.fastcompany.com
url:
  https://www.fastcompany.com/90750720/3-disabled-workers-share-how-returning-to-normal-makes-work-inaccessible?partner=rss&utm_campaign=rss+fastcompany&utm_content=rss&utm_medium=feed&utm_source=rss


id: amwa-171
domain: www.eeoc.gov
url:
  https://www.eeoc.gov/employers/small-business/4-what-cant-i-ask-when-hiring#:~:text=you%20can%20ask%20the%20applicant,medications%20are%20you%20currently%20taking%3f


id: amwa-171
domain: www.cnet.com
url:
  https://www.cnet.com/tech/mobile/the-original-voice-of-siri-is-now-advocating-for-a-more-accessible-web


id: amwa-46
domain: www.wiley.com
url:
  https://www.wiley.com/network/professionals/healthcare-publishing-trends/396901-a4-wp-publishing-in-the-digital-era


id: amwa-46
domain: www.bu.edu
url:
  https://www.bu.edu/academics/met/programs/graduate-certificate-in-visual-digital-health-communication


id: amwa-46
domain: static1.squarespace.com
url:
  https://static1.squarespace.com/static/5854aaa044024321a353bb0d/t/5a527aa89140b76bbfb2028a/1515354827682/visualabstract_primer_v4_1.pdf


id: amwa-46
domain: www.pharmaceutical-tech.com
url:
  https://www.pharmaceutical-tech.com/articles/medical-writing-services-in-asia-recent-developments-and-trends


id: amwa-193
domain: home.treasury.gov
url:
  https://home.treasury.gov/policy-issues/financial-sanctions/sanctions-programs-and-country-information


id: amwa-193
domain: home.treasury.gov
url:
  https://home.treasury.gov/policy-issues/financial-sanctions/specially-designated-nationals-and-blocked-persons-list-sdn-human-readable-lists


id: amwa-25
domain: nexus.od.nih.gov
url:
  https://nexus.od.nih.gov/all/2016/01/29/consideration-of-relevant-biological-variables-in-nih-grant-applications


id: amwa-151
domain: www.afb.org
url:
  https://www.afb.org/consulting/afb-accessibility-resources/afbs-social-media-accessibility-standards


id: amwa-139
domain: headbookworm.com
url:
  https://headbookworm.com/wp-content/uploads/2020/10/amwa-2020-low-cost-and-low-effort-infographics-and-visually-appealing-slides-handout.pdf


id: amwa-215
domain: www.nbcnews.com
url:
  https://www.nbcnews.com/news/nbcblk/black-doctors-mourntulsa-hospital-shooting-victim-dr-preston-phillips-rcna31846


id: amwa-215
domain: www.nbcnews.com
url:
  https://www.nbcnews.com/news/nbcblk/black-doctors-mourn-tulsa-hospital-shooting-victim-dr-preston-phillips-rcna31846


id: amwa-170
domain: www.fda.gov
url:
  https://www.fda.gov/patients/learn-aboutexpanded-access-and-other-treatment-options/understandingunapproved-use-approved-drugs-label


id: amwa-170
domain: accme.org
url:
  https://accme.org/sites/default/files/2021-06/884_20210624_new%20standards%20standalone%20package.pdf


id: amwa-170
domain: www.fda.gov
url:
  https://www.fda.gov/patients/learn-about-expanded-access-and-other-treatment-options/understanding-unapproved-use-approved-drugs-label


id: amwa-170
domain: accme.org
url:
  https://accme.org/sites/default/files/2020-12/883_20201210_standards%20for%20integrity%20and%20independence%20toolkit.pdf


id: amwa-210
domain: www.arnoldporter.com
url:
  www.arnoldporter.com/en/perspectives/blogs/enforcementedge/2022/07/uk-proposes-framework-for-regulating-ai


id: amwa-210
domain: www.arnoldporter.com
url:
  https://www.arnoldporter.com/en/perspectives/blogs/enforcement-edge/2022/07/uk-proposes-framework-for-regulating-ai


id: amwa-249
domain: www.icmje.org
url:
  https://www.icmje.org/recommendations/browse/roles-and-responsibilities/defining-the-role-of-authors-and-contributors.html


id: amwa-249
domain: cse.memberclicks.net
url:
  https://www.councilscienceeditors.org/recommendations-for-promoting-integrity-in-scientific-journal-publicationshttps://www.councilscienceeditors.org/recommendations-for-promoting-integrity-in-scientific-journal-publicationshttps://www.councilscienceeditors.org/recommendations-for-promoting-integrity-in-scientific-journal-publicationshttps://cse.memberclicks.net/assets/docs/2023/cse-white-paper_feb2022_webpdf.pdf


id: amwa-224
domain: gskpro.com
url:
  https://gskpro.com/content/dam/global/hcpportal/en_us/prescribing_information/blenrep/pdf/blenrep-pi-mg.pdf


id: amwa-224
domain: www.fda.gov
url:
  https://www.fda.gov/drugs/resources-informationapproved-drugs/fda-approves-fam-trastuzumab-deruxtecannxki-her2-positive-gastric-adenocarcinomas


id: amwa-224
domain: www.personalizedmedicinecoalition.org
url:
  http://www.personalizedmedicinecoalition.org/userfiles/pmc-corporate/file/the_evolution_of_biomarker_use_in_clinical_trials_for_cancer_treatments.pdf


id: amwa-224
domain: www.fda.gov
url:
  https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-regular-approval-fam-trastuzumab-deruxtecan-nxki-breast-cancer


id: amwa-224
domain: www.fda.gov
url:
  https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-fam-trastuzumab-deruxtecan-nxki-her2-positive-gastric-adenocarcinomas


id: amwa-224
domain: www.fda.gov
url:
  https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-accelerated-approval-fam-trastuzumab-deruxtecan-nxki-her2-mutant-non-small-cell-lung


id: amwa-224
domain: www.fda.gov
url:
  https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-fam-trastuzumab-deruxtecan-nxki-her2-low-breast-cancer


id: amwa-278
domain: www.pewresearch.org
url:
  www.pewresearch.org/fact-tank/2021/04/16/americansoverwhelmingly-say-marijuana-should-be-legal-for-recreationalor-medical-use


id: amwa-278
domain: www.forbes.com
url:
  https://www.forbes.com/sites/irisdorbian/2021/06/18/legal-cannabis-market-projected-to-rack-up-43-billion-by-2025-says-new-study/?sh=35f070d336b4


id: amwa-278
domain: www.pewresearch.org
url:
  https://www.pewresearch.org/fact-tank/2021/04/16/americans-overwhelmingly-say-marijuana-should-be-legal-for-recreational-or-medical-use


id: amwa-278
domain: www.federalregister.gov
url:
  https://www.federalregister.gov/documents/2019/04/03/2019-06436/scientific-data-and-information-about-products-containing-cannabis-or-cannabis-derived-compounds


id: amwa-278
domain: www.federalregister.gov
url:
  https://www.federalregister.gov/documents/2015/09/18/2015-23389/consumer-comments-public-posting-and-availability-of-comments-submitted-to-food-and-drug#furinf


id: amwa-278
domain: obamawhitehouse.archives.gov
url:
  https://obamawhitehouse.archives.gov/the-pressoffice/2011/01/18/executive-order-13563-improving-regulationand-regulatory-review


id: amwa-278
domain: static1.squarespace.com
url:
  https://static1.squarespace.com/static/5e26633cfcf7d67bbd350a7f/t/60682893c386f915f4b05e43/1617438916753/leximancer+user+guide+4.5.pdf


id: amwa-278
domain: obamawhitehouse.archives.gov
url:
  https://obamawhitehouse.archives.gov/the-press-office/2011/01/18/executive-order-13563-improving-regulation-and-regulatory-review


id: amwa-176
domain: slate.com
url:
  https://slate.com/technology/2012/01/the-nuremberg-code-set-up-to-protect-the-human-subjects-of-research-is-being-routinely-ignored.html


id: amwa-250
domain: www.icmje.org
url:
  https://www.icmje.org/recommendations/browse/roles-and-responsibilities/defining-the-role-of-authors-and-contributors.html#two


id: amwa-250
domain: scopeblog.stanford.edu
url:
  https://scopeblog.stanford.edu/2021/12/13/whos-on-first-duking-out-scientific-paper-authorship-order


id: amwa-299
domain: www.forbes.com
url:
  https://www.forbes.com/sites/forbesfinancecouncil/2020/09/18/why-you-should-make-financial-literacy-part-of-your-company-culture/?sh=6b0b85aa2c39


id: amwa-195
domain: www.independent.co.uk
url:
  https://www.independent.co.uk/voices/phrase-peopleperson-colour-bme-black-woman-women-different-experiencesrace-racism-a7868586.html


id: amwa-195
domain: www.independent.co.uk
url:
  https://www.independent.co.uk/voices/phrase-people-person-colour-bme-black-woman-women-different-experiences-race-racism-a7868586.html


id: amwa-241
domain: www.fda.gov
url:
  https://www.fda.gov/medical-devices/software-medicaldevice-samd/artificial-intelligence-and-machine-learningsoftware-medical-device


id: amwa-241
domain: www.fda.gov
url:
  https://www.fda.gov/media/109618/download#:~:text=the%20food%20and%20drug%20administration%20%28fda%29%20has%20long,therefore%20subject%20to%20fda%20oversight%20as%20a%20device


id: amwa-241
domain: www.nytimes.com
url:
  https://www.nytimes.com/interactive/2020/11/21/science/artificial-intelligence-fake-people-faces.html


id: amwa-241
domain: www.fda.gov
url:
  https://www.fda.gov/medical-devices/software-medical-device-samd/good-machine-learning-practice-medical-device-development-guiding-principles


id: amwa-241
domain: www.fda.gov
url:
  https://www.fda.gov/medical-devices/software-medical-device-samd/artificial-intelligence-and-machine-learning-software-medical-device


id: amwa-234
domain: www.newsweek.com
url:
  https://www.newsweek.com/madison-cawthornsays-door-door-vaccines-could-lead-taking-gunsbibles-1608503)


id: amwa-234
domain: www.newsweek.com
url:
  https://www.newsweek.com/madison-cawthorn-says-door-door-vaccines-could-lead-taking-guns-bibles-1608503


id: amwa-267
domain: www.nasw.org
url:
  https://www.nasw.org/events/nasw-science-writers-nationalconference-sciwri23-annual-meeting-2023-boulder-colorado


id: amwa-267
domain: www.nasw.org
url:
  https://www.nasw.org/events/nasw-science-writers-national-conference-sciwri23-annual-meeting-2023-boulder-colorado


id: amwa-156
domain: ec.europa.eu
url:
  https://ec.europa.eu/health/system/files/2020-02/2017_01_26_summaries_of_ct_results_for_laypersons_0.pdf


id: amwa-156
domain: mrctcenter.org
url:
  https://mrctcenter.org/wp-content/uploads/2017/12/2017-12-07-mrct-return-of-aggregate-results-guidance-document-3.1.pdf


id: amwa-276
domain: www.openpharma.blog
url:
  https://www.openpharma.blog/wp-content/uploads/2021/08/pls-trs-plsp-crib-sheet_open-pharma_17aug21.pdf


id: amwa-276
domain: www.openpharma.blog
url:
  https://www.openpharma.blog/wp-content/uploads/2021/02/open-pharma-educational-materials-open-access.pdf


id: amwa-276
domain: www.ukri.org
url:
  https://www.ukri.org/what-we-do/supporting-healthy-research-and-innovation-culture/open-research/open-access-policies-review/#:~:text=uk%20research%20and%20innovation%20(ukri,published%20from%201%20january%202024


id: amwa-276
domain: oir.nih.gov
url:
  https://oir.nih.gov/sourcebook/intramural-program-oversight/intramural-data-sharing/2023-nih-data-management-sharing-policy#:~:text=the%20nih%20has%20issued%20a,products%20that%20improve%20human%20health


id: amwa-276
domain: web.archive.org
url:
  https://web.archive.org/web/20230201191040/https:/www.ipsen.com/ipsen-commits-to-making-all-its-published-scientific-research-freely-accessible-to-everyone


id: amwa-276
domain: www.glpg.com
url:
  https://www.glpg.com/our-story/590/galapagos-commits-to-open-access-policy#:~:text=galapagos%20has%20committed%20to%20an,of%20its%20commitment%20to%20transparency


id: amwa-276
domain: www.lens.org
url:
  https://www.lens.org/lens/report/view/**open-pharma-open-access-analysis-dashboard**/14572/page/14573


id: amwa-276
domain: www.openpharma.blog
url:
  https://www.openpharma.blog/blog/news/perceptions-and-insights-on-clinical-trial-participation-results-from-the-2021-ciscrp-study


id: amwa-276
domain: www.openpharma.blog
url:
  https://www.openpharma.blog/blog/accessibility/open-access/improving-equity-through-open-access-education


id: amwa-276
domain: www.openpharma.blog
url:
  https://www.openpharma.blog/blog/accessibility/open-access/the-changing-open-research-landscape-a-publishers-perspective


id: amwa-276
domain: www.openpharma.blog
url:
  https://www.openpharma.blog/blog/guest-posts/improve-research-discoverability-to-support-health-literacy


id: amwa-276
domain: www.openpharma.blog
url:
  https://www.openpharma.blog/blog/guest-posts/the-changing-open-research-landscape-a-publishers-perspective


id: amwa-276
domain: www.openpharma.blog
url:
  https://www.openpharma.blog/blog/news/pharma-and-publishers-forum-an-open-pharma-roundtable-discussion-on-plain-language-summaries


id: amwa-276
domain: www.openpharma.blog
url:
  https://www.openpharma.blog/blog/news/pharma-and-publishers-forum-an-open-pharma-roundtable-discussion-on-open-access


id: amwa-276
domain: www.openpharma.blog
url:
  https://www.openpharma.blog/blog/discoverability/pharma-and-publishers-forum-an-open-pharma-roundtable-discussion-on-discoverability


id: amwa-276
domain: www.openpharma.blog
url:
  https://www.openpharma.blog/blog/news/pharma-and-publishers-forum-an-open-pharma-roundtable-discussion-on-data-sharing


id: amwa-276
domain: www.ipsos.com
url:
  https://www.ipsos.com/sites/default/files/ct/publication/documents/2023-01/ipsos-global-trustworthiness-monitor-2022-charts.pdf


id: amwa-276
domain: www.ipsos.com
url:
  https://www.ipsos.com/sites/default/files/ct/publication/documents/2023-01/ipsos-global-trustworthiness-monitor-stability-in-an-unstable-world.pdf


id: amwa-276
domain: sfdora.org
url:
  https://sfdora.org/2023/06/30/how-research-assessment-reform-can-help-research-to-do-more-reflections-from-the-sdg-publishers-compact-fellows-open-climate-campaign-and-open-pharma


id: amwa-276
domain: www.openpharma.blog
url:
  https://www.openpharma.blog/wp-content/uploads/2021/01/how-open-are-pharma-publications_ismpp-eu-2020.pdf


id: amwa-276
domain: www.openpharma.blog
url:
  https://www.openpharma.blog/wp-content/uploads/2021/04/freeman-et-al_how-openly-accessible-is-pharma-sponsored-research-an-informatics-approach_ismppeu2021.pdf


id: amwa-276
domain: www.openpharma.blog
url:
  https://www.openpharma.blog/blog/accessibility/open-access/reflections-and-predictions-at-the-turn-of-the-year


id: amwa-276
domain: www.openpharma.blog
url:
  https://www.openpharma.blog/blog/news/open-pharma-talk-shows-available-on-youtube-listen-understand-act


id: amwa-160
domain: www.smithsonianmag.com
url:
  https://www.smithsonianmag.com/artsculture/the-origin-of-the-pilcrow-aka-the-strange-paragraphsymbol-8610683


id: amwa-160
domain: www.smithsonianmag.com
url:
  https://www.smithsonianmag.com/arts-culture/the-origin-of-the-pilcrow-aka-the-strange-paragraph-symbol-8610683


id: amwa-266
domain: today.uconn.edu
url:
  https://today.uconn.edu/2022/04/the-human-genome-projectpieced-together-92-of-the-dna-now-scientists-have-finally-filledin-the-remaining-8


id: amwa-266
domain: www.science.org
url:
  https://www.science.org/content/webinar/tiny-influencers-outsized-impacts-unraveling-how-microbiomes-modulate-our-health


id: amwa-266
domain: today.uconn.edu
url:
  https://today.uconn.edu/2022/04/the-human-genome-project-pieced-together-92-of-the-dna-now-scientists-have-finally-filled-in-the-remaining-8


id: amwa-266
domain: blogs.scientificamerican.com
url:
  https://blogs.scientificamerican.com/food-matters/the-microbiomes-of-indigenous-peoples-are-different-does-it-matter


id: amwa-122
domain: support.microsoft.com
url:
  https://support.microsoft.com/en-us/office/view-resource-workloads-and-availability-in-project-desktop-3ee16869-68ad-4e63-bcb3-278ae34f7459


id: amwa-179
domain: www.cdp.net
url:
  https://www.cdp.net/en/articles/media/new-report-showsjust-100-companies-are-source-of-over-70-of-emissions


id: amwa-179
domain: www.un.org
url:
  https://www.un.org/womenwatch/feature/climate_change/downloads/women_and_climate_change_factsheet.pdf


id: amwa-179
domain: www.epa.gov
url:
  https://www.epa.gov/newsreleases/epa-report-shows-disproportionate-impacts-climate-change-socially-vulnerable


id: amwa-179
domain: www.cdp.net
url:
  https://www.cdp.net/en/articles/media/new-report-shows-just-100-companies-are-source-of-over-70-of-emissions


id: amwa-236
domain: www.accme.org
url:
  https://www.accme.org/accreditation-rules/standardsfor-integrity-independence-accredited-ce/standard-2-preventcommercial-bias-and-marketing-accredited-continuing


id: amwa-236
domain: www.accme.org
url:
  https://www.accme.org/accreditation-rules/standards-for-integrity-independence-accredited-ce/standard-2-prevent-commercial-bias-and-marketing-accredited-continuing


id: amwa-196
domain: www.legacy.com
url:
  https://www.legacy.com/obituaries/whig/obituary.aspx?n=nancy-swanberg-bradshaw&pid=180120975&fhid=17874


id: amwa-196
domain: grahamschool.uchicago.edu
url:
  https://grahamschool.uchicago.edu/academic-programs/professional-development/medical-writing-and-editing


id: amwa-408
domain: www.ideagen.com
url:
  https://www.ideagen.com/solutions/document-collaboration/life-sciences-pleasereview?utm_source=amwa+journal+&utm_medium=referral&utm_term=learn-more&utm_content=amwa-journal-advert-1&utm_campaign=fy25-all-comp-plr-gen-amwa-newsletter-ad


id: amwa-272
domain: www.elsevier.com
url:
  https://www.elsevier.com/about/policies/publishing-ethics/the-use-of-ai-and-ai-assisted-writing-technologies-in-scientific-writing


id: amwa-301
domain: www.pewtrusts.org
url:
  https://www.pewtrusts.org/en/research-and-analysis/reports/0001/01/01/conflictsofinterest-policies-for-academic-medical-centers


id: amwa-393
domain: www.nytimes.com
url:
  https://www.nytimes.com/1976/09/12/archives/a-chromosomelink-to-crime-is-doubted-study-in-denmark-finds-no.html


id: amwa-393
domain: www.nytimes.com
url:
  https://www.nytimes.com/1976/09/12/archives/a-chromosome-link-to-crime-is-doubted-study-in-denmark-finds-no.html


id: amwa-192
domain: www.researchandmarkets.com
url:
  https://www.researchandmarkets.com/reports/5544417/u-scontinuing-medical-education-market?gclid=cj0kcqjwrs2xbhdj


id: amwa-192
domain: accme.org
url:
  https://accme.org/publications/standards-for-integrity-and-independence-accredited-continuing-education-pdf


id: amwa-192
domain: www.researchandmarkets.com
url:
  https://www.researchandmarkets.com/reports/5544417/u-s-continuing-medical-education-market?gclid=cj0kcqjwrs2xbhdjarisahvymmrpk5kmdzfrcdu9hvg8dvbxin5hy456ee0g0rtztlyamu_oxvvmxhmaajw6ealw_wcb


id: amwa-300
domain: www.icmje.org
url:
  www.icmje.org/recommendations/browse/roles-andresponsibilities/defining-the-role-of-authors-andcontributors.html


id: amwa-300
domain: www.aamc.org
url:
  https://www.aamc.org/professionaldevelopment/affinity-groups/cfas/diversity-inclusiontoolkit/resources


id: amwa-300
domain: www.commonwealthfund.org
url:
  https://www.commonwealthfund.org/sites/default/files/documents/___media_files_publications_fund_report_2002_oct_cultural_competence_in_health_care__emerging_frameworks_and_practical_approaches_betancourt_culturalcompetence_576_pdf.pdf


id: amwa-300
domain: www.aamc.org
url:
  https://www.aamc.org/professional-development/affinity-groups/cfas/diversity-inclusion-toolkit/resources


id: amwa-380
domain: www.health.gov.au
url:
  www.health.gov.au/topics/chronic-conditions/whatwere-doing-about-chronic-conditions/what-were-doingabout-cardiovascular-conditions?utm_source=health.gov


id: amwa-380
domain: www.who.int
url:
  https://www.who.int/news/item/03-032003-who-fao-release-independent-expert-report-on-diet-andchronic-disease


id: amwa-380
domain: ama.com.au
url:
  https://ama.com.au/positionstatement/social-determinants-health-and-prevention-healthinequities-2007


id: amwa-380
domain: www.health.gov.au
url:
  https://www.health.gov.au/topics/chronic-conditions/what-were-doing-about-chronic-conditions/what-were-doing-about-cardiovascular-conditions?utm_source=health.gov.au&utm_medium=callout-auto-custom&utm_campaign=digital_transformation


id: amwa-380
domain: www.who.int
url:
  https://www.who.int/news/item/03-03-2003-who-fao-release-independent-expert-report-on-diet-and-chronic-disease


id: amwa-380
domain: ama.com.au
url:
  https://ama.com.au/position-statement/social-determinants-health-and-prevention-health-inequities-2007


id: amwa-353
domain: www.pewresearch.org
url:
  https://www.pewresearch.org/short-reads/2023/11/21/what-the-data-says-about-americans-views-of-artificial-intelligence


id: amwa-353
domain: www.fda.gov
url:
  https://www.fda.gov/medicaldevices/software-medical-device-samd/good-machine-learningpractice-medical-device-development-guiding-principles


id: amwa-322
domain: postgraduateeducation.hms.harvard.edu
url:
  https://postgraduateeducation.hms.harvard.edu/certificate-programs/effective-writing-health-care?utm_source=amwa&utm_medium=display&utm_campaign=ewhc2025


id: amwa-385
domain: www.healthypeople.gov
url:
  https://wayback.archive-it.org/5774/20220413181905/https://www.healthypeople.gov/2020/topics-objectives/topic/heart-disease-and-stroke


id: amwa-479
domain: www.icmje.org
url:
  https://www.icmje.org/recommendations/browse/roles-andresponsibilities/defining-the-role-of-authors-and-contributors


id: amwa-384
domain: www.forbes.com
url:
  https://www.forbes.com/sites/joemckendrick/2023/10/14/half-of-all-skills-will-be-outdated-within-two-years-study-suggests


id: amwa-384
domain: press.edx.org
url:
  https://press.edx.org/edx-survey-finds-nearly-half-49-of-ceos-believe-most-or-all-of-their-role-should-be-automated-or-replaced-by-ai


id: amwa-384
domain: www.fastcompany.com
url:
  https://www.fastcompany.com/91011036/the-5-skills-workers-value-the-most-in-2024-according-to-new-research


id: amwa-384
domain: www.linkedin.com
url:
  https://www.linkedin.com/business/talent/blog/talent-strategy/linkedin-most-in-demand-hard-and-soft-skills


# ent

id: amwa-91
sid: 159
eid: 1
type: PRODUCT
entity:
  https://topdogsocialmedia.com/linkedin-changes/ https://topdogsocialmedia.com/linkedin-changes/ https://blog.hubspot.com/sales/how-to-write-an-effective-linkedin-headline https://blog.hubspot.com/sales/how-to-write-an-effective-linkedin-headline https://blog.hubspot.com/sales/how-to-write-an-effective-linkedin-headline https://neilpatel.com/blog/linkedin-headlines/ https://neilpatel.com/blog/linkedin-headlines/ https://www.socialmediaexaminer.com/how-to-use-linkedin-featured-section-on-your-profile/ https://www.linkedin.com/help/linkedin/answer/110/your-network-and-degrees-of-connection?lang=en


id: amwa-101
sid: 147
eid: 1
type: ORG
entity:
  https://www.fiercebiotech.com/biotech/2022talent-war-life-sciences-salary-inflation-c-suite-builds-tonegative-feedback-loop 3


id: amwa-93
sid: 183
eid: 1
type: LOC
entity:
  ftc.gov/news-events/press-releases/2019/04/court-rules-ftcs-favoragainst-predatory-academic-publisher-omics 7


id: amwa-146
sid: 17
eid: 14
type: PRODUCT
entity:
  https://www.councilscienceeditors.org/events/upcomingevents/2021-cse-annual-meeting/ european medical writers association


id: amwa-150
sid: 15
eid: 11
type: PERSON
entity:
  miceli jennifer minarcik marcello morgan margaret norris julie phelan john redue jessica reimer stephanie vargas ann


id: amwa-105
sid: 25
eid: 8
type: PRODUCT
entity:
  mailto:managingeditor@amwa.org http://www.amwa.org/journal mailto:marketing@amwa.org mailto:amwa@amwa.org


id: amwa-142
sid: 190
eid: 1
type: ORG
entity:
  https://www.theatlantic.com/health/archive/2017/02/when-evidence-says-no-but-doctors-say-yes/517368/


id: amwa-125
sid: 95
eid: 1
type: ORG
entity:
  https://shop.lww.com/stedman-s-plus-2022medical-pharmaceutical-spellchecker--single-userdownload-/p/9781975183677 •


id: amwa-98
sid: 218
eid: 1
type: PERSON
entity:
  https://www.mayoclinic.org/documents/mc2386-au07-pdf/doc-20078983 https://www.mayoclinic.org/documents/mc2386-au07-pdf/doc-20078983 https://www.mayoclinic.org/documents/mc2386-au07-pdf/doc-20078983 https://www.mayoclinicproceedings.org/pb/assets/raw/health%20advance/journals/jmcp/if1.pdf https://www.mayoclinicproceedings.org/pb/assets/raw/health%20advance/journals/jmcp/if1.pdf


id: amwa-126
sid: 287
eid: 2
type: PERSON
entity:
  http://dx.doi.org/10.1108/ejm-09-2011-0515 http://dx.doi.org/10.1108/ejm-09-2011-0515 http://dx.doi.org/10.1109/47.968105


id: amwa-193
sid: 84
eid: 2
type: NORP
entity:
  treasury.gov/policy-issues/financial-sanctions/speciallydesignated-nationals-and-blocked-persons-list-sdnhuman-readable-lists


id: amwa-17
sid: 156
eid: 1
type: DATE
entity:
  https://www.fda.gov/regulatory-information/search-fda-guidancedocuments/statistical-considerations-clinical-trials-during-covid-19public-health-emergency-guidance-industry 21


id: amwa-17
sid: 233
eid: 1
type: PERSON
entity:
  https://www.the-scientist.com/bio-business/how-the-pharma-industry-pulled-off-the-pivot-to-covid-19-67719 https://www.the-scientist.com/bio-business/how-the-pharma-industry-pulled-off-the-pivot-to-covid-19-67719 https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020 https://www.ncbi.nlm.nih.gov/nuccore/mn908947


id: amwa-17
sid: 234
eid: 1
type: ORG
entity:
  https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-takes-new-actions-accelerate-development-novel-prevention-treatment https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-takes-new-actions-accelerate-development-novel-prevention-treatment https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-takes-new-actions-accelerate-development-novel-prevention-treatment https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-takes-new-actions-accelerate-development-novel-prevention-treatment https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-takes-new-actions-accelerate-development-novel-prevention-treatment


id: amwa-17
sid: 234
eid: 2
type: ORG
entity:
  https://www.fda.gov/regulatory-information/search-fda-guidance-documents/covid-19-developing-drugs-and-biological-products-treatment-or-prevention https://www.fda.gov/regulatory-information/search-fda-guidance-documents/statistical-considerations-clinical-trials-during-covid-19-public-health-emergency-guidance-industry https://www.fda.gov/regulatory-information/search-fda-guidance-documents/statistical-considerations-clinical-trials-during-covid-19-public-health-emergency-guidance-industry https://www.fda.gov/regulatory-information/search-fda-guidance-documents/statistical-considerations-clinical-trials-during-covid-19-public-health-emergency-guidance-industry https://www.fda.gov/regulatory-information/search-fda-guidance-documents/statistical-considerations-clinical-trials-during-covid-19-public-health-emergency-guidance-industry https://www.fda.gov/regulatory-information/search-fda-guidance-documents/development-and-licensure-vaccines-prevent-covid-19 https://www.fda.gov/regulatory-information/search-fda-guidance-documents/development-and-licensure-vaccines-prevent-covid-19 https://www.fda.gov/regulatory-information/search-fda-guidance-documents/development-and-licensure-vaccines-prevent-covid-19 https://www.fda.gov/regulatory-information/search-fda-guidance-documents/development-and-licensure-vaccines-prevent-covid-19 https://www.fda.gov/regulatory-information/search-fda-guidance-documents/development-and-licensure-vaccines-prevent-covid-19


id: amwa-17
sid: 242
eid: 1
type: DATE
entity:
  https://www.who.int/news/item/0312-2020-global-access-to-covid-19-vaccines-estimated-to-generateeconomic-benefits-of-at-least-153-billion-in-2020-21 39


id: amwa-43
sid: 213
eid: 1
type: PERSON
entity:
  https://medium.com/sutherland-labs/patient-experience-design-a-game-changer-for-health https://medium.com/sutherland-labs/patient-experience-design-a-game-changer-for-healthcare-31351623e010


id: amwa-13
sid: 226
eid: 1
type: ORG
entity:
  doi:10.1038/nature00786 mailto:jennifer.busch@wheaton.edu https://doi.org/10.1155/2020/6159720 https://doi.org/10.1002/ccd.29179


id: amwa-13
sid: 374
eid: 1
type: PERSON
entity:
  http://www.heart.org https://www.heart.org/en/news/2020/05/18/is-high-blood-pressure-inevitable-heres-how-to-keep-it-in-check https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/people-with-medical-conditions.html


id: amwa-13
sid: 427
eid: 1
type: PERSON
entity:
  https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-diseasehttps://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-diseasehttps://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/pfizer-biontech-covid-19-vaccine https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/pfizer-biontech-covid-19-vaccine


id: amwa-25
sid: 123
eid: 2
type: ORG
entity:
  https://grants.nih.gov/grants/guide/notice-files/not-od-10-019.html http://www.agwa.us/ethics https://grantprofessionals.org/page/ethics https://www.nih.gov/about-nih/what-we-do/budget


id: amwa-45
sid: 114
eid: 1
type: PERSON
entity:
  https://spyrestudios.com/the-anatomy-of-an-infographic-5-steps-to-create-a-powerful-visual/ https://spyrestudios.com/the-anatomy-of-an-infographic-5-steps-to-create-a-powerful-visual/ http://www.amwa.org/mwc


id: amwa-171
sid: 132
eid: 1
type: PERSON
entity:
  https://www.eeoc.gov/laws/guidance/enforcement-guidance-preemployment-disability-related-questions-and-medical#self-identify https://www.eeoc.gov/laws/guidance/enforcement-guidance-preemployment-disability-related-questions-and-medical#self-identify https://www.shrm.org/resourcesandtools/hr-topics/talent-acquisition/documents/employing_people_with_disabilities_toolkit_february_3_2015_v4.pdf https://www.shrm.org/resourcesandtools/hr-topics/talent-acquisition/documents/employing_people_with_disabilities_toolkit_february_3_2015_v4.pdf https://www.shrm.org/resourcesandtools/hr-topics/talent-acquisition/documents/employing_people_with_disabilities_toolkit_february_3_2015_v4.pdf https://www.shrm.org/resourcesandtools/hr-topics/talent-acquisition/documents/employing_people_with_disabilities_toolkit_february_3_2015_v4.pdf https://blog.amwa.org/equity-inclusion-tips#:~:text=in%20her%20amwa%20webinar%2c%20writing,differences%2c%20and%20promotes%20equal%20opportunities https://blog.amwa.org/equity-inclusion-tips#:~:text=in%20her%20amwa%20webinar%2c%20writing,differences%2c%20and%20promotes%20equal%20opportunities https://blog.amwa.org/equity-inclusion-tips#:~:text=in%20her%20amwa%20webinar%2c%20writing,differences%2c%20and%20promotes%20equal%20opportunities


id: amwa-171
sid: 132
eid: 2
type: ORG
entity:
  https://disabilityin.org/resource/six-tips-to-keep-in-mind-when-creating-accessible-virtual-meetings/ https://disabilityin.org/resource/six-tips-to-keep-in-mind-when-creating-accessible-virtual-meetings/ https://disabilityin.org/resource/six-tips-to-keep-in-mind-when-creating-accessible-virtual-meetings/


id: amwa-171
sid: 140
eid: 1
type: GPE
entity:
  www.fastcompany.com/90750720/3-disabled-workers-share-howreturning-to-normal-makes-work-inaccessible?partner=rss&utm


id: amwa-171
sid: 192
eid: 1
type: ORG
entity:
  https://www.fastcompany.com/90750720/3-disabled-workers-share-how-returning-to-normal-makes-work-inaccessible?partner=rss&utm_campaign=rss+fastcompany&utm_content=rss&utm_medium=feed&utm_source=rss https://www.fastcompany.com/90750720/3-disabled-workers-share-how-returning-to-normal-makes-work-inaccessible?partner=rss&utm_campaign=rss+fastcompany&utm_content=rss&utm_medium=feed&utm_source=rss https://www.fastcompany.com/90750720/3-disabled-workers-share-how-returning-to-normal-makes-work-inaccessible?partner=rss&utm_campaign=rss+fastcompany&utm_content=rss&utm_medium=feed&utm_source=rss https://www.fastcompany.com/90750720/3-disabled-workers-share-how-returning-to-normal-makes-work-inaccessible?partner=rss&utm_campaign=rss+fastcompany&utm_content=rss&utm_medium=feed&utm_source=rss https://www.fastcompany.com/90750720/3-disabled-workers-share-how-returning-to-normal-makes-work-inaccessible?partner=rss&utm_campaign=rss+fastcompany&utm_content=rss&utm_medium=feed&utm_source=rss https://disabilityin.org/ceos-are-in/


id: amwa-46
sid: 21
eid: 1
type: PERSON
entity:
  https://players.brightcove.net/656326989001/default_default/index https://players.brightcove.net/656326989001/default_default/index.html?videoid=5824269862001


id: amwa-46
sid: 166
eid: 3
type: PERSON
entity:
  https://www.wiley.com/network/professionals/healthcare-publishing-trends/396901-a4-wp-publishing-in-the-digital-era https://doi.org/10.1016/j.teln.2019.09.003


id: amwa-46
sid: 167
eid: 1
type: ORG
entity:
  https://doi.org/10.1017/cem.2018.436 https://doi.org/10.1002/bjs.11307 https://www.pharmaceutical-tech.com/articles/medical-writing-services-in-asia-recent-developments-and-trends


id: amwa-82
sid: 186
eid: 1
type: DATE
entity:
  https:// www.forbes.com/sites/brentgleeson/2013/10/02/the-silo-mentalityhow-to-break-down-the-barriers/ 15


id: amwa-82
sid: 294
eid: 1
type: ORG
entity:
  https://globalforum.diaglobal.org/issue/may-2020/medical-writing-the-language-and-art-of-scientific-communication/ https://www.healthwriterhub.com/a-medical-writers-skillset https://www.healthwriterhub.com/medical-writing-skills/ https://www.impactpharma.com/blog/what-skills-do-you-need-to-be-a-good-regulatory-medical-writer/ https://acrpnet.org/2019/11/12/evaluating-the-role-of-the-regulatory-writer/ https://www.trilogywriting.com/publications/do-you-measure-up/


id: amwa-128
sid: 3
eid: 15
type: ORG
entity:
  tbd https://www.asindexing.org/conferences/future-annualconferences/ association of health care journalists


id: amwa-90
sid: 224
eid: 1
type: PERSON
entity:
  https://en.wikipedia.org/wiki/walter_c._alvarez https://en.wikipedia.org/wiki/walter_c._alvarez https://en.wikipedia.org/wiki/luis_f._alvarez


id: amwa-90
sid: 224
eid: 2
type: PERSON
entity:
  https://www.encyclopedia.com/people/science-and-technology/physics-biographies/luis-walter-alvarez https://en.wikipedia.org/wiki/walter_alvarez https://en.wikipedia.org/wiki/walter_alvarez


id: amwa-90
sid: 224
eid: 3
type: PERSON
entity:
  https://www.wikitree.com/wiki/alvarez-1582 https://ancestors.familysearch.org/en/lvf4-tt3/dr-walter-clement-alvarez-1884-1978 https://ancestors.familysearch.org/en/lvf4-tt3/dr-walter-clement-alvarez-1884-1978 https://ancestors.familysearch.org/en/lvf4-tt3/dr-walter-clement-alvarez-1884-1978 https://karsh.org/a-brief-biography/


id: amwa-215
sid: 97
eid: 1
type: ORG
entity:
  the http://www.amwajournal.org https://www.nbcnews.com/news/nbcblk/black-doctors-mourn-tulsa-hospital-shooting-victim-dr-preston-phillips-rcna31846 https://www.nbcnews.com/news/nbcblk/black-doctors-mourn-tulsa-hospital-shooting-victim-dr-preston-phillips-rcna31846 https://www.bostonmagazine.com/news/2015/06/30/brigham-and-womens-hospital-shooting/ https://www.bostonmagazine.com/news/2015/06/30/brigham-and-womens-hospital-shooting/


id: amwa-230
sid: 167
eid: 1
type: PRODUCT
entity:
  https://www.bls.gov/ooh/healthcare/physicians-and-surgeons.htm#tab-2 https://www.bls.gov/ooh/healthcare/physicians-and-surgeons.htm#tab-2


id: amwa-224
sid: 463
eid: 1
type: PERSON
entity:
  https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-regular-approval-fam-trastuzumab-deruxtecan-nxki-breast-cancer https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-regular-approval-fam-trastuzumab-deruxtecan-nxki-breast-cancer https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-regular-approval-fam-trastuzumab-deruxtecan-nxki-breast-cancer https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-fam-trastuzumab-deruxtecan-nxki-her2-positive-gastric-adenocarcinomas https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-fam-trastuzumab-deruxtecan-nxki-her2-positive-gastric-adenocarcinomas https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-fam-trastuzumab-deruxtecan-nxki-her2-positive-gastric-adenocarcinomas https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-accelerated-approval-fam-trastuzumab-deruxtecan-nxki-her2-mutant-non-small-cell-lung https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-accelerated-approval-fam-trastuzumab-deruxtecan-nxki-her2-mutant-non-small-cell-lung https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-accelerated-approval-fam-trastuzumab-deruxtecan-nxki-her2-mutant-non-small-cell-lung https://www.fda.gov/drugs/resources-information-approved-drugs/fda-grants-accelerated-approval-fam-trastuzumab-deruxtecan-nxki-her2-mutant-non-small-cell-lung


id: amwa-250
sid: 159
eid: 2
type: ORG
entity:
  https://scopeblog.stanford.edu/2021/12/13/whos-on-first-duking-out-scientific-paper-authorship-order/ https://scopeblog.stanford.edu/2021/12/13/whos-on-first-duking-out-scientific-paper-authorship-order/ https://credit.niso.org/


id: amwa-245
sid: 5
eid: 1
type: PRODUCT
entity:
  https://customer.sspnet.org/ssp/ssp/am23/home.aspx?hkey=22abbe1c-7a5d-45c5-9a39-183b3535d1b6 https://customer.sspnet.org/ssp/ssp/am23/home.aspx?hkey=22abbe1c-7a5d-45c5-9a39-183b3535d1b6 https://www.diaglobal.org/en/flagship/dia-2023


id: amwa-241
sid: 184
eid: 2
type: ORG
entity:
  http://www.amwajournal.org https://www.fda.gov/media/109618/download#:~:text=the%20food%20and%20drug%20administration%20%28fda%29%20has%20long,therefore%20subject%20to%20fda%20oversight%20as%20a%20device https://www.fda.gov/media/109618/download#:~:text=the%20food%20and%20drug%20administration%20%28fda%29%20has%20long,therefore%20subject%20to%20fda%20oversight%20as%20a%20device https://www.fda.gov/media/109618/download#:~:text=the%20food%20and%20drug%20administration%20%28fda%29%20has%20long,therefore%20subject%20to%20fda%20oversight%20as%20a%20device https://www.fda.gov/media/109618/download#:~:text=the%20food%20and%20drug%20administration%20%28fda%29%20has%20long,therefore%20subject%20to%20fda%20oversight%20as%20a%20device https://www.fda.gov/media/109618/download#:~:text=the%20food%20and%20drug%20administration%20%28fda%29%20has%20long,therefore%20subject%20to%20fda%20oversight%20as%20a%20device


id: amwa-294
sid: 3
eid: 14
type: ORG
entity:
  argentina https://plainlanguagenetwork.org/conferences/2023-buenos-airesargentina/ international society for medical


id: amwa-272
sid: 146
eid: 1
type: PERSON
entity:
  https://www.icmje.org/recommendations/browse/roles-and-responsibilities/defining-the-role-of-authors-and-contributors.html https://www.icmje.org/recommendations/browse/roles-and-responsibilities/defining-the-role-of-authors-and-contributors.html https://www.thelancet.com/journals/landig/article/piis2589-7500(23)00019-5/fulltext https://www.thelancet.com/journals/landig/article/piis2589-7500(23)00019-5/fulltext https://www.thelancet.com/journals/landig/article/piis2589-7500(23)00019-5/fulltext


id: amwa-122
sid: 169
eid: 1
type: ORG
entity:
  http://www.amwajournal.org https://www.fda.gov/media/137927/download https://www.fda.gov/media/137927/download https://www.fda.gov/media/137926/download https://www.fda.gov/media/137926/download https://www.fda.gov/media/139145/download


id: amwa-122
sid: 170
eid: 1
type: PERSON
entity:
  https://support.microsoft.com/en-us/office/view-resource-workloads-and-availability-in-project-desktop-3ee16869-68ad-4e63-bcb3-278ae34f7459 https://support.microsoft.com/en-us/office/view-resource-workloads-and-availability-in-project-desktop-3ee16869-68ad-4e63-bcb3-278ae34f7459 https://support.microsoft.com/en-us/office/view-resource-workloads-and-availability-in-project-desktop-3ee16869-68ad-4e63-bcb3-278ae34f7459 https://support.microsoft.com/en-us/office/view-resource-workloads-and-availability-in-project-desktop-3ee16869-68ad-4e63-bcb3-278ae34f7459 https://docs.microsoft.com/en-us/office/troubleshoot/project/calculate-work-duration-assignment https://docs.microsoft.com/en-us/office/troubleshoot/project/calculate-work-duration-assignment https://docs.microsoft.com/en-us/power-bi/connect-data/service-connect-to-project-online https://docs.microsoft.com/en-us/power-bi/connect-data/service-connect-to-project-online


id: amwa-192
sid: 171
eid: 1
type: ORG
entity:
  https://www.researchandmarkets.com/reports/5544417/u-scontinuing-medical-education-market?gclid=cj0kcqjwrs2xbhdj arisahvymmrpk5kmdzfrcdu9hvg8dvbxin5hy456ee0g0rtzt lyamu_oxvvmxhmaajw6ealw_wcb •


id: amwa-267
sid: 3
eid: 30
type: ORG
entity:
  argentina https://plainlanguagenetwork.org/conferences/2023-buenosaires-argentina/ society of clinical research


id: amwa-267
sid: 4
eid: 27
type: PERSON
entity:
  https://www.the-efa.org/event/efa-conference-efacon/ https://theacse.com/2023/ https://www.medicalwriters.org/events/


id: amwa-236
sid: 84
eid: 1
type: PERSON
entity:
  www.amwa.org/career_steps http://www.amwajournal.org https://www.accme.org/sites/default/files/2022-10/2021%20accme%20data%20report_967_20221005.pdf https://www.accme.org/sites/default/files/2022-10/2021%20accme%20data%20report_967_20221005.pdf https://www.accme.org/sites/default/files/2022-10/2021%20accme%20data%20report_967_20221005.pdf https://www.accme.org/accreditation-rules/standards-for-integrity-independence-accredited-ce/standard-2-prevent-commercial-bias-and-marketing-accredited-continuing https://www.accme.org/accreditation-rules/standards-for-integrity-independence-accredited-ce/standard-2-prevent-commercial-bias-and-marketing-accredited-continuing https://www.accme.org/accreditation-rules/standards-for-integrity-independence-accredited-ce/standard-2-prevent-commercial-bias-and-marketing-accredited-continuing https://info.amwa.org/regulatory-writer-training-ebook


id: amwa-300
sid: 32
eid: 2
type: PERSON
entity:
  cathryn d. evans http://www.amwajournal.org https://accme.org/publications/standards-for-integrity-and-independence-accredited-continuing-education-pdf https://accme.org/publications/standards-for-integrity-and-independence-accredited-continuing-education-pdf amwajournal.org 18freelance


id: amwa-300
sid: 91
eid: 5
type: TIME
entity:
  https://www.accme.org/accreditation-rules/accreditation-criteria https://www.accme.org/accreditation-rules/accreditation-criteria https://www.icmje.org/recommendations/browse/roles-and-responsibilities/defining-the-role-of-authors-and-contributors.html https://www.icmje.org/recommendations/browse/roles-and-responsibilities/defining-the-role-of-authors-and-contributors.html https://www.icmje.org/recommendations/browse/roles-and-responsibilities/defining-the-role-of-authors-and-contributors.html https://www.icmje.org/recommendations/browse/roles-and-responsibilities/defining-the-role-of-authors-and-contributors.html https://www.aamc.org/professional-development/affinity-groups/cfas/diversity-inclusion-toolkit/resources


id: amwa-276
sid: 98
eid: 1
type: PERSON
entity:
  https://journal.emwa.org/open-science-and-open-pharma/ https://www.openpharma.blog/blog/#sign-up-to-our-newsletter


id: amwa-276
sid: 98
eid: 2
type: ORG
entity:
  https://www.openpharma.blog/blog/opinion/how-pharma-will-help-move-the-needle-on-open-research/ https://www.openpharma.blog/blog/news/perceptions-and-insights-on-clinical-trial-participation-results-from-the-2021-ciscrp-study/ https://www.openpharma.blog/blog/news/perceptions-and-insights-on-clinical-trial-participation-results-from-the-2021-ciscrp-study/ https://www.openpharma.blog/blog/opinion/open-science-reflecting-upon-real-world-impact-podcasts/


id: amwa-276
sid: 216
eid: 1
type: PERSON
entity:
  https://www.nlm.nih.gov/pubs/techbull/jf19/jf19_february_pubmed_updates.html https://www.nlm.nih.gov/pubs/techbull/jf19/jf19_february_pubmed_updates.html


id: amwa-276
sid: 216
eid: 2
type: PERSON
entity:
  https://www.openpharma.blog/blog/news/open-pharma-launches-data-sharing-needs-assessment-survey/ https://www.openpharma.blog/blog/news/open-pharma-launches-data-sharing-needs-assessment-survey/


id: amwa-276
sid: 216
eid: 3
type: GPE
entity:
  https://www.openpharma.blog/blog/accessibility/open-access/reflections-and-predictions-at-the-turn-of-the-year/


id: amwa-257
sid: 105
eid: 2
type: ORG
entity:
  http://www.amwajournal.org https://www.fda.gov/science-research/science-and-research-special-topics/real-world-evidence https://www.fda.gov/science-research/science-and-research-special-topics/real-world-evidence


id: amwa-333
sid: 131
eid: 2
type: ORG
entity:
  http://www.amwajournal.org https://www.iso.org/standard/78907.html https://www.iso.org/standard/78907.html https://www.iso.org/standards.html https://www.ich.org/ https://www.iplfederation.org/iso-standard/ https://www.iplfederation.org/iso-standard/


id: amwa-266
sid: 185
eid: 3
type: ORG
entity:
  http://www.amwajournal.org https://www.science.org/content/webinar/tiny-influencers-outsized-impacts-unraveling-how-microbiomes-modulate-our-health https://www.science.org/content/webinar/tiny-influencers-outsized-impacts-unraveling-how-microbiomes-modulate-our-health https://www.science.org/content/webinar/tiny-influencers-outsized-impacts-unraveling-how-microbiomes-modulate-our-health https://today.uconn.edu/2022/04/the-human-genome-project-pieced-together-92-of-the-dna-now-scientists-have-finally-filled-in-the-remaining-8/ https://today.uconn.edu/2022/04/the-human-genome-project-pieced-together-92-of-the-dna-now-scientists-have-finally-filled-in-the-remaining-8/ https://today.uconn.edu/2022/04/the-human-genome-project-pieced-together-92-of-the-dna-now-scientists-have-finally-filled-in-the-remaining-8/


id: amwa-314
sid: 3
eid: 19
type: PERSON
entity:
  ma https://www.raps.org/events/raps-global-regulatory-strategyconference-2024 drug information association


id: amwa-380
sid: 230
eid: 2
type: ORG
entity:
  https://cdn.who.int/media/docs/default-source/country-profiles/ncds/kna_en.pdf https://cdn.who.int/media/docs/default-source/country-profiles/ncds/kna_en.pdf


id: amwa-385
sid: 130
eid: 1
type: PERSON
entity:
  https://iris.paho.org/bitstream/handle/10665.2/28393/9789275118863_eng.pdf https://iris.paho.org/bitstream/handle/10665.2/28393/9789275118863_eng.pdf https://www.who.int/health-topics/cardiovascular-diseases#tab=tab_1 https://www.who.int/health-topics/cardiovascular-diseases#tab=tab_1


# pos

id: amwa-20
sid: 79
tid: 1
pos: NOUN
token:
  https://www.windowscentral.com/thereare-now-12-billion-office-users-60-million-office-365-commercialcustomers

lemma:
  https://www.windowscentral.com/thereare-now-12-billion-office-users-60-million-office-365-commercialcustomer


id: amwa-20
sid: 83
tid: 17
pos: NOUN
token:
  https://www.windowscentral.com/there-are-now-12-billion-office-users-60-million-office-365-commercial-customers

lemma:
  https://www.windowscentral.com/there-are-now-12-billion-office-users-60-million-office-365-commercial-customer


id: amwa-91
sid: 127
tid: 1
pos: VERB
token:
  https://www.themuse.com/advice/allstarlinkedin-users-are-40-times-more-likely-to-get-contactedheres-how-toscore-that-rating

lemma:
  https://www.themuse.com/advice/allstarlinkedin-users-are-40-times-more-likely-to-get-contactedheres-how-toscore-that-rate


id: amwa-91
sid: 159
tid: 2
pos: VERB
token:
[cell repeats an earlier one in this file: 125 characters]

lemma:
  https://www.themuse.com/advice/allstar-linkedin-users-are-40-times-more-likely-to-get-contactedheres-how-to-score-that-rate


id: amwa-155
sid: 153
tid: 19
pos: PROPN
token:
  https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/

lemma:
  https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/


id: amwa-93
sid: 183
tid: 3
pos: PROPN
token:
  ftc.gov/news-events/press-releases/2019/04/court-rules-ftcs-favoragainst-predatory-academic-publisher-omics

lemma:
  ftc.gov/news-events/press-releases/2019/04/court-rules-ftcs-favoragainst-predatory-academic-publisher-omics


id: amwa-93
sid: 189
tid: 8
pos: NOUN
token:
  https://www.ftc.gov/news-events/press-releases/2019/04/court-rules-ftcs-favor-against-predatory-academic-publisher-omics

lemma:
  https://www.ftc.gov/news-events/press-releases/2019/04/court-rules-ftcs-favor-against-predatory-academic-publisher-omic


id: amwa-142
sid: 190
tid: 17
pos: NOUN
token:
[cell repeats an earlier one in this file: 160 characters]

lemma:
  https://www.who.int/emergencies/diseases/novel-coronavirus-2019/global-research-on-novel-coronavirus-2019-ncov/solidarity-clinical-trial-for-covid-19-treatment


id: amwa-142
sid: 190
tid: 20
pos: ADJ
token:
  https://www.newsweek.com/2017/04/14/prescription-drug-pricing-569444.html#:~:text=reimbursement%20is%20the%20amount%20the,as%20a%20pharmacy%20benefit%20manager

lemma:
  https://www.newsweek.com/2017/04/14/prescription-drug-pricing-569444.html#:~:text=reimbursement%20is%20the%20amount%20the,as%20a%20pharmacy%20benefit%20manag


id: amwa-193
sid: 103
tid: 8
pos: NOUN
token:
[cell repeats an earlier one in this file: 140 characters]

lemma:
  https://home.treasury.gov/policy-issues/financial-sanctions/specially-designated-nationals-and-blocked-persons-list-sdn-human-readable-list


id: amwa-43
sid: 213
tid: 13
pos: NOUN
token:
  https://ww2.frost.com/news/press-releases/telehealth-to-experience-massive-growth-with-covid-19-pandemic-says-frost-sullivan/

lemma:
  https://ww2.frost.com/news/press-releases/telehealth-to-experience-massive-growth-with-covid-19-pandemic-says-frost-sullivan/


id: amwa-171
sid: 132
tid: 13
pos: NOUN
token:
[cell repeats an earlier one in this file: 146 characters]

lemma:
  https://blog.amwa.org/equity-inclusion-tips#:~:text=in%20her%20amwa%20webinar%2c%20writing,differences%2c%20and%20promotes%20equal%20opportunitie


id: amwa-171
sid: 132
tid: 23
pos: NOUN
token:
  https://disabilityin.org/resource/six-tips-to-keep-in-mind-when-creating-accessible-virtual-meetings/

lemma:
  https://disabilityin.org/resource/six-tips-to-keep-in-mind-when-creating-accessible-virtual-meetings/


id: amwa-171
sid: 170
tid: 1
pos: PROPN
token:
  https://www.cnet.com/tech/mobile/theoriginal-voice-of-siri-is-now-advocating-for-a-more-accessibleweb/

lemma:
  https://www.cnet.com/tech/mobile/theoriginal-voice-of-siri-is-now-advocating-for-a-more-accessibleweb/


id: amwa-171
sid: 193
tid: 6
pos: PROPN
token:
  https://www.cnet.com/tech/mobile/the-original-voice-of-siri-is-now-advocating-for-a-more-accessible-web/

lemma:
  https://www.cnet.com/tech/mobile/the-original-voice-of-siri-is-now-advocating-for-a-more-accessible-web/


id: amwa-17
sid: 116
tid: 1
pos: NOUN
token:
  https://www.fda.gov/news-events/press-announcements/fdaannounces-key-actions-advance-development-novel-coronavirusmedical-countermeasures

lemma:
  https://www.fda.gov/news-events/press-announcements/fdaannounces-key-actions-advance-development-novel-coronavirusmedical-countermeasure


id: amwa-17
sid: 121
tid: 3
pos: PROPN
token:
  fda.gov/emergency-preparedness-and-response/mcm-legal-regulatoryand-policy-framework/emergency-use-authorization

lemma:
  fda.gov/emergency-preparedness-and-response/mcm-legal-regulatoryand-policy-framework/emergency-use-authorization


id: amwa-17
sid: 126
tid: 1
pos: NOUN
token:
  https://www.fda.gov/regulatory-information/search-fdaguidance-documents/emergency-use-authorization-medical-productsand-related-authorities

lemma:
  https://www.fda.gov/regulatory-information/search-fdaguidance-documents/emergency-use-authorization-medical-productsand-related-authoritie


id: amwa-17
sid: 136
tid: 1
pos: VERB
token:
  https://www.fda.gov/regulatoryinformation/search-fda-guidance-documents/policy-coronavirusdisease-2019-tests-during-public-health-emergency-revised

lemma:
  https://www.fda.gov/regulatoryinformation/search-fda-guidance-documents/policy-coronavirusdisease-2019-tests-during-public-health-emergency-revise


id: amwa-17
sid: 146
tid: 1
pos: VERB
token:
  https://www.fda.gov/regulatory-information/search-fda-guidancedocuments/covid-19-public-health-emergency-general-considerationspre-ind-meeting-requests-covid-19-related

lemma:
  https://www.fda.gov/regulatory-information/search-fda-guidancedocuments/covid-19-public-health-emergency-general-considerationspre-ind-meeting-requests-covid-19-relate


id: amwa-17
sid: 171
tid: 3
pos: PROPN
token:
  fda.gov/emergency-preparedness-and-response/coronavirus-disease2019-covid-19/pfizer-biontech-covid-19-vaccine

lemma:
  fda.gov/emergency-preparedness-and-response/coronavirus-disease2019-covid-19/pfizer-biontech-covid-19-vaccine


id: amwa-17
sid: 181
tid: 2
pos: VERB
token:
  www.who.int/emergencies/diseases/novel-coronavirus-2019/globalresearch-on-novel-coronavirus-2019-ncov/solidarity-clinical-trial-forcovid-19-treatments

lemma:
  www.who.int/emergencies/diseases/novel-coronavirus-2019/globalresearch-on-novel-coronavirus-2019-ncov/solidarity-clinical-trial-forcovid-19-treatment


id: amwa-17
sid: 230
tid: 1
pos: NOUN
token:
  https://www.fda.gov/regulatory-information/searchfda-guidance-documents/assessing-covid-19-related-symptomsoutpatient-adult-and-adolescent-subjects-clinical-trials-drugs

lemma:
  https://www.fda.gov/regulatory-information/searchfda-guidance-documents/assessing-covid-19-related-symptomsoutpatient-adult-and-adolescent-subjects-clinical-trials-drug


id: amwa-17
sid: 233
tid: 6
pos: NOUN
token:
[cell repeats an earlier one in this file: 139 characters]

lemma:
  https://www.fda.gov/news-events/press-announcements/fda-announces-key-actions-advance-development-novel-coronavirus-medical-countermeasure


id: amwa-17
sid: 233
tid: 12
pos: VERB
token:
  https://www.fda.gov/regulatory-information/search-fda-guidance-documents/emergency-use-authorization-medical-products-and-related-authorities

lemma:
  https://www.fda.gov/regulatory-information/search-fda-guidance-documents/emergency-use-authorization-medical-products-and-related-authoritie


id: amwa-17
sid: 234
tid: 4
pos: VERB
token:
[cell repeats an earlier one in this file: 149 characters]

lemma:
  https://www.fda.gov/regulatory-information/search-fda-guidance-documents/policy-coronavirus-disease-2019-tests-during-public-health-emergency-revise


id: amwa-17
sid: 234
tid: 13
pos: VERB
token:
[cell repeats an earlier one in this file: 170 characters]

lemma:
  https://www.fda.gov/regulatory-information/search-fda-guidance-documents/covid-19-public-health-emergency-general-considerations-pre-ind-meeting-requests-covid-19-relate


id: amwa-17
sid: 235
tid: 9
pos: ADJ
token:
  https://www.europeanpharmaceuticalreview.com/news/128134/impact-of-covid-19-on-clinical-trials-continuing-say-researchers/

lemma:
  https://www.europeanpharmaceuticalreview.com/news/128134/impact-of-covid-19-on-clinical-trials-continuing-say-researchers/


id: amwa-17
sid: 235
tid: 13
pos: NOUN
token:
[cell repeats an earlier one in this file: 126 characters]

lemma:
  https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-issues-guidance-conducting-clinical-trial


id: amwa-17
sid: 235
tid: 18
pos: NOUN
token:
[cell repeats an earlier one in this file: 171 characters]

lemma:
  https://www.fda.gov/regulatory-information/search-fda-guidance-documents/assessing-covid-19-related-symptoms-outpatient-adult-and-adolescent-subjects-clinical-trials-drug


id: amwa-17
sid: 298
tid: 3
pos: NOUN
token:
  https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/early-investigations

lemma:
  https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/early-investigation


id: amwa-17
sid: 298
tid: 5
pos: NOUN
token:
  https://www.nih.gov/news-events/news-releases/nih-launch-public-private-partnership-speed-covid-19-vaccine-treatment-options

lemma:
  https://www.nih.gov/news-events/news-releases/nih-launch-public-private-partnership-speed-covid-19-vaccine-treatment-option


id: amwa-17
sid: 298
tid: 6
pos: VERB
token:
  https://www.nih.gov/news-events/news-releases/nih-launches-clinical-trials-network-test-covid-19-vaccines-other-prevention-tools

lemma:
  https://www.nih.gov/news-events/news-releases/nih-launches-clinical-trials-network-test-covid-19-vaccines-other-prevention-tool


id: amwa-13
sid: 374
tid: 9
pos: PROPN
token:
  https://clinicaltrials.gov/ct2/results?cond=covid19&term=ace%2c+arb&type=&rslt=&recrs=a&recrs=f&recrs=d&age_v=&gndr=&intr=&titles=&outc=&spons=&lead=&id=&cntry=&state=&city=&dist=&locn=&rsub=&strd_s=&strd_e=&prcd_s=&prcd_e=&sfpd_s=&sfpd_e=&rfpd_s=&rfpd_e=&lupd_s=&lupd_e=&sort=

lemma:
  https://clinicaltrials.gov/ct2/results?cond=covid19&term=ace%2c+arb&type=&rslt=&recrs=a&recrs=f&recrs=d&age_v=&gndr=&intr=&titles=&outc=&spons=&lead=&id=&cntry=&state=&city=&dist=&locn=&rsub=&strd_s=&strd_e=&prcd_s=&prcd_e=&sfpd_s=&sfpd_e=&rfpd_s=&rfpd_e=&lupd_s=&lupd_e=&sort=


id: amwa-13
sid: 384
tid: 3
pos: VERB
token:
  covid19treatmentguidelines.nih.gov/antiviral-therapy/lopinavirritonavir-and-other-hiv-protease-inhibitors/

lemma:
  covid19treatmentguidelines.nih.gov/antiviral-therapy/lopinavirritonavir-and-other-hiv-protease-inhibitors/


id: amwa-13
sid: 427
tid: 2
pos: PROPN
token:
  https://www.covid19treatmentguidelines.nih.gov/antiviral-therapy/chloroquine-or-hydroxychloroquine-with-or-without-azithromycin/

lemma:
  https://www.covid19treatmentguidelines.nih.gov/antiviral-therapy/chloroquine-or-hydroxychloroquine-with-or-without-azithromycin/


id: amwa-13
sid: 427
tid: 3
pos: PROPN
token:
  https://www.covid19treatmentguidelines.nih.gov/antiviral-therapy/lopinavir-ritonavir-and-other-hiv-protease-inhibitors/

lemma:
  https://www.covid19treatmentguidelines.nih.gov/antiviral-therapy/lopinavir-ritonavir-and-other-hiv-protease-inhibitors/


id: amwa-46
sid: 166
tid: 75
pos: PROPN
token:
  https://www.bu.edu/academics/met/programs/graduate-certificate-in-visual-digital-health-communication/

lemma:
  https://www.bu.edu/academics/met/programs/graduate-certificate-in-visual-digital-health-communication/


id: amwa-46
sid: 167
tid: 8
pos: VERB
token:
  https://www.pharmaceutical-tech.com/articles/medical-writing-services-in-asia-recent-developments-and-trends

lemma:
  https://www.pharmaceutical-tech.com/articles/medical-writing-services-in-asia-recent-developments-and-trend


id: amwa-25
sid: 179
tid: 3
pos: PROPN
token:
  https://nexus.od.nih.gov/all/2016/01/29/consideration-of-relevant-biological-variables-in-nih-grant-applications/

lemma:
  https://nexus.od.nih.gov/all/2016/01/29/consideration-of-relevant-biological-variables-in-nih-grant-applications/


id: amwa-168
sid: 142
tid: 2
pos: ADP
token:
  vaccinesafety.info/2021/08/26/the-thalidomide-tragedy-lessonsfor-drug-safety-and-regulation-helix-magazine/

lemma:
  vaccinesafety.info/2021/08/26/the-thalidomide-tragedy-lessonsfor-drug-safety-and-regulation-helix-magazine/


id: amwa-82
sid: 293
tid: 1
pos: PROPN
token:
  https://www.forbes.com/sites/brentgleeson/2013/10/02/the-silo-mentality-how-to-break-down-the-barriers/

lemma:
  https://www.forbes.com/sites/brentgleeson/2013/10/02/the-silo-mentality-how-to-break-down-the-barriers/


id: amwa-82
sid: 294
tid: 12
pos: PROPN
token:
  https://globalforum.diaglobal.org/issue/may-2020/medical-writing-the-language-and-art-of-scientific-communication/

lemma:
  https://globalforum.diaglobal.org/issue/may-2020/medical-writing-the-language-and-art-of-scientific-communication/


id: amwa-14
sid: 122
tid: 3
pos: NOUN
token:
  emwa.org/writing-better/amwa-emwa-ismpp-joint-position-statementon-the-role-of-professional-medical-writers

lemma:
  emwa.org/writing-better/amwa-emwa-ismpp-joint-position-statementon-the-role-of-professional-medical-writer


id: amwa-14
sid: 196
tid: 10
pos: NOUN
token:
  http://journal.emwa.org/writing-better/amwa-emwa-ismpp-joint-position-statement-on-the-role-of-professional-medical-writers

lemma:
  http://journal.emwa.org/writing-better/amwa-emwa-ismpp-joint-position-statement-on-the-role-of-professional-medical-writer


id: amwa-278
sid: 154
tid: 2
pos: PROPN
token:
  www.pewresearch.org/fact-tank/2021/04/16/americansoverwhelmingly-say-marijuana-should-be-legal-for-recreationalor-medical-use/

lemma:
  www.pewresearch.org/fact-tank/2021/04/16/americansoverwhelmingly-say-marijuana-should-be-legal-for-recreationalor-medical-use/


id: amwa-278
sid: 179
tid: 8
pos: NOUN
token:
  https://www.pewresearch.org/fact-tank/2021/04/16/americans-overwhelmingly-say-marijuana-should-be-legal-for-recreational-or-medical-use/

lemma:
  https://www.pewresearch.org/fact-tank/2021/04/16/americans-overwhelmingly-say-marijuana-should-be-legal-for-recreational-or-medical-use/


id: amwa-278
sid: 179
tid: 12
pos: NOUN
token:
[cell repeats an earlier one in this file: 160 characters]

lemma:
  https://www.federalregister.gov/documents/2019/04/03/2019-06436/scientific-data-and-information-about-products-containing-cannabis-or-cannabis-derived-compound


id: amwa-224
sid: 435
tid: 1
pos: NOUN
token:
  https://www.fda.gov/drugs/resources-informationapproved-drugs/fda-approves-fam-trastuzumab-deruxtecannxki-her2-positive-gastric-adenocarcinomas

lemma:
  https://www.fda.gov/drugs/resources-informationapproved-drugs/fda-approves-fam-trastuzumab-deruxtecannxki-her2-positive-gastric-adenocarcinoma


id: amwa-250
sid: 159
tid: 37
pos: PROPN
token:
  https://scopeblog.stanford.edu/2021/12/13/whos-on-first-duking-out-scientific-paper-authorship-order/

lemma:
  https://scopeblog.stanford.edu/2021/12/13/whos-on-first-duking-out-scientific-paper-authorship-order/


id: amwa-241
sid: 184
tid: 16
pos: NOUN
token:
[cell repeats an earlier one in this file: 141 characters]

lemma:
  https://www.fda.gov/medical-devices/software-medical-device-samd/good-machine-learning-practice-medical-device-development-guiding-principle


id: amwa-234
sid: 120
tid: 38
pos: NOUN
token:
  https://www.newsweek.com/madison-cawthornsays-door-door-vaccines-could-lead-taking-gunsbibles-1608503

lemma:
  https://www.newsweek.com/madison-cawthornsays-door-door-vaccines-could-lead-taking-gunsbibles-1608503


id: amwa-272
sid: 145
tid: 2
pos: VERB
token:
  https://www.elsevier.com/about/policies/publishing-ethics/the-use-of-ai-and-ai-assisted-writing-technologies-in-scientific-writing

lemma:
  https://www.elsevier.com/about/policies/publishing-ethics/the-use-of-ai-and-ai-assisted-writing-technologies-in-scientific-write


id: amwa-236
sid: 68
tid: 1
pos: VERB
token:
  https://www.accme.org/accreditation-rules/standardsfor-integrity-independence-accredited-ce/standard-2-preventcommercial-bias-and-marketing-accredited-continuing

lemma:
  https://www.accme.org/accreditation-rules/standardsfor-integrity-independence-accredited-ce/standard-2-preventcommercial-bias-and-marketing-accredited-continue


id: amwa-236
sid: 84
tid: 6
pos: VERB
token:
[cell repeats an earlier one in this file: 163 characters]

lemma:
  https://www.accme.org/accreditation-rules/standards-for-integrity-independence-accredited-ce/standard-2-prevent-commercial-bias-and-marketing-accredited-continue


id: amwa-122
sid: 159
tid: 1
pos: NOUN
token:
  microsoft.com/en-us/office/view-resource-workloads-andavailability-in-project-desktop-3ee16869-68ad-4e63-bcb3278ae34f7459

lemma:
  microsoft.com/en-us/office/view-resource-workloads-andavailability-in-project-desktop-3ee16869-68ad-4e63-bcb3278ae34f7459


id: amwa-179
sid: 111
tid: 1
pos: NOUN
token:
  https://www.cdp.net/en/articles/media/new-report-showsjust-100-companies-are-source-of-over-70-of-emissions

lemma:
  https://www.cdp.net/en/articles/media/new-report-showsjust-100-companies-are-source-of-over-70-of-emission


id: amwa-179
sid: 163
tid: 11
pos: NOUN
token:
  https://www.cdp.net/en/articles/media/new-report-shows-just-100-companies-are-source-of-over-70-of-emissions

lemma:
  https://www.cdp.net/en/articles/media/new-report-shows-just-100-companies-are-source-of-over-70-of-emission


id: amwa-300
sid: 91
tid: 65
pos: NOUN
token:
  https://www.aamc.org/professionaldevelopment/affinity-groups/cfas/diversity-inclusiontoolkit/resources

lemma:
  https://www.aamc.org/professionaldevelopment/affinity-groups/cfas/diversity-inclusiontoolkit/resource


id: amwa-300
sid: 91
tid: 111
pos: NOUN
token:
[cell repeats an earlier one in this file: 104 characters]

lemma:
  https://www.aamc.org/professional-development/affinity-groups/cfas/diversity-inclusion-toolkit/resource


id: amwa-276
sid: 76
tid: 2
pos: NOUN
token:
  https://web.archive.org/web/20230201191040/https:/www.ipsen.com/ipsen-commits-to-making-all-its-published-scientific-research-freely-accessible-to-everyone/

lemma:
  https://web.archive.org/web/20230201191040/https:/www.ipsen.com/ipsen-commits-to-making-all-its-published-scientific-research-freely-accessible-to-everyone/


id: amwa-276
sid: 98
tid: 6
pos: NOUN
token:
  https://www.openpharma.blog/blog/news/perceptions-and-insights-on-clinical-trial-participation-results-from-the-2021-ciscrp-study/

lemma:
  https://www.openpharma.blog/blog/news/perceptions-and-insights-on-clinical-trial-participation-results-from-the-2021-ciscrp-study/


id: amwa-276
sid: 98
tid: 9
pos: PROPN
token:
  https://www.openpharma.blog/blog/accessibility/open-access/improving-equity-through-open-access-education/

lemma:
  https://www.openpharma.blog/blog/accessibility/open-access/improving-equity-through-open-access-education/


id: amwa-276
sid: 98
tid: 10
pos: PROPN
token:
  https://www.openpharma.blog/blog/accessibility/open-access/the-changing-open-research-landscape-a-publishers-perspective/

lemma:
  https://www.openpharma.blog/blog/accessibility/open-access/the-changing-open-research-landscape-a-publishers-perspective/


id: amwa-276
sid: 98
tid: 11
pos: PROPN
token:
  https://www.openpharma.blog/blog/guest-posts/improve-research-discoverability-to-support-health-literacy/

lemma:
  https://www.openpharma.blog/blog/guest-posts/improve-research-discoverability-to-support-health-literacy/


id: amwa-276
sid: 108
tid: 1
pos: PROPN
token:
  https://www.openpharma.blog/blog/guest-posts/the-changing-open-research-landscape-a-publishers-perspective/

lemma:
  https://www.openpharma.blog/blog/guest-posts/the-changing-open-research-landscape-a-publishers-perspective/


id: amwa-276
sid: 108
tid: 2
pos: PROPN
token:
  https://www.openpharma.blog/blog/news/pharma-and-publishers-forum-an-open-pharma-roundtable-discussion-on-plain-language-summaries/

lemma:
  https://www.openpharma.blog/blog/news/pharma-and-publishers-forum-an-open-pharma-roundtable-discussion-on-plain-language-summaries/


id: amwa-276
sid: 108
tid: 3
pos: PROPN
token:
  https://www.openpharma.blog/blog/news/pharma-and-publishers-forum-an-open-pharma-roundtable-discussion-on-open-access/

lemma:
  https://www.openpharma.blog/blog/news/pharma-and-publishers-forum-an-open-pharma-roundtable-discussion-on-open-access/


id: amwa-276
sid: 108
tid: 4
pos: ADJ
token:
  https://www.openpharma.blog/blog/discoverability/pharma-and-publishers-forum-an-open-pharma-roundtable-discussion-on-discoverability/

lemma:
  https://www.openpharma.blog/blog/discoverability/pharma-and-publishers-forum-an-open-pharma-roundtable-discussion-on-discoverability/


id: amwa-276
sid: 108
tid: 5
pos: X
token:
  https://www.openpharma.blog/blog/news/pharma-and-publishers-forum-an-open-pharma-roundtable-discussion-on-data-sharing/

lemma:
  https://www.openpharma.blog/blog/news/pharma-and-publishers-forum-an-open-pharma-roundtable-discussion-on-data-sharing/


id: amwa-276
sid: 147
tid: 2
pos: ADJ
token:
  sfdora.org/2023/06/30/how-research-assessment-reform-canhelp-research-to-do-more-reflections-from-the-sdg-publisherscompact-fellows-open-climate-campaign-and-open-pharma/

lemma:
  sfdora.org/2023/06/30/how-research-assessment-reform-canhelp-research-to-do-more-reflections-from-the-sdg-publisherscompact-fellows-open-climate-campaign-and-open-pharma/


id: amwa-276
sid: 185
tid: 1
pos: PROPN
token:
  openpharma.blog/wp-content/uploads/2021/04/freemanet-al_how-openly-accessible-is-pharma-sponsored-research-aninformatics-approach_ismppeu2021.pdf

lemma:
  openpharma.blog/wp-content/uploads/2021/04/freemanet-al_how-openly-accessible-is-pharma-sponsored-research-aninformatics-approach_ismppeu2021.pdf


id: amwa-276
sid: 216
tid: 11
pos: NUM
token:
  https://sfdora.org/2023/06/30/how-research-assessment-reform-can-help-research-to-do-more-reflections-from-the-sdg-publishers-compact-fellows-open-climate-campaign-and-open-pharma/

lemma:
  https://sfdora.org/2023/06/30/how-research-assessment-reform-can-help-research-to-do-more-reflections-from-the-sdg-publishers-compact-fellows-open-climate-campaign-and-open-pharma/


id: amwa-276
sid: 216
tid: 36
pos: PROPN
token:
  https://www.openpharma.blog/blog/news/open-pharma-talk-shows-available-on-youtube-listen-understand-act/

lemma:
  https://www.openpharma.blog/blog/news/open-pharma-talk-shows-available-on-youtube-listen-understand-act/


id: amwa-266
sid: 147
tid: 1
pos: PROPN
token:
  https://today.uconn.edu/2022/04/the-human-genome-projectpieced-together-92-of-the-dna-now-scientists-have-finally-filledin-the-remaining-8/

lemma:
  https://today.uconn.edu/2022/04/the-human-genome-projectpieced-together-92-of-the-dna-now-scientists-have-finally-filledin-the-remaining-8/


id: amwa-266
sid: 185
tid: 16
pos: PROPN
token:
  https://today.uconn.edu/2022/04/the-human-genome-project-pieced-together-92-of-the-dna-now-scientists-have-finally-filled-in-the-remaining-8/

lemma:
  https://today.uconn.edu/2022/04/the-human-genome-project-pieced-together-92-of-the-dna-now-scientists-have-finally-filled-in-the-remaining-8/


id: amwa-266
sid: 329
tid: 27
pos: VERB
token:
  https://blogs.scientificamerican.com/food-matters/the-microbiomes-of-indigenous-peoples-are-different-does-it-matter/

lemma:
  https://blogs.scientificamerican.com/food-matters/the-microbiomes-of-indigenous-peoples-are-different-does-it-matter/


id: amwa-301
sid: 126
tid: 16
pos: NOUN
token:
[cell repeats an earlier one in this file: 127 characters]

lemma:
  https://www.pewtrusts.org/en/research-and-analysis/reports/0001/01/01/conflictsofinterest-policies-for-academic-medical-center


id: amwa-353
sid: 93
tid: 1
pos: PROPN
token:
  pewresearch.org/short-reads/2023/11/21/what-the-data-saysabout-americans-views-of-artificial-intelligence/

lemma:
  pewresearch.org/short-reads/2023/11/21/what-the-data-saysabout-americans-views-of-artificial-intelligence/


id: amwa-353
sid: 100
tid: 1
pos: VERB
token:
  https://www.pewresearch.org/short-reads/2023/11/21/what-the-data-says-about-americans-views-of-artificial-intelligence/

lemma:
  https://www.pewresearch.org/short-reads/2023/11/21/what-the-data-says-about-americans-views-of-artificial-intelligence/


id: amwa-353
sid: 109
tid: 1
pos: NOUN
token:
  https://www.fda.gov/medicaldevices/software-medical-device-samd/good-machine-learningpractice-medical-device-development-guiding-principles

lemma:
  https://www.fda.gov/medicaldevices/software-medical-device-samd/good-machine-learningpractice-medical-device-development-guiding-principle


id: amwa-479
sid: 249
tid: 1
pos: NOUN
token:
  https://www.icmje.org/recommendations/browse/roles-andresponsibilities/defining-the-role-of-authors-and-contributors

lemma:
  https://www.icmje.org/recommendations/browse/roles-andresponsibilities/defining-the-role-of-authors-and-contributor


id: amwa-384
sid: 89
tid: 1
pos: PROPN
token:
  https://www.forbes.com/sites/joemckendrick/2023/10/14/half-of-all-skills-will-be-outdated-within-two-years-study-suggests/

lemma:
  https://www.forbes.com/sites/joemckendrick/2023/10/14/half-of-all-skills-will-be-outdated-within-two-years-study-suggests/


id: amwa-384
sid: 89
tid: 10
pos: NOUN
token:
[cell repeats an earlier one in this file: 106 characters]

lemma:
  https://www.linkedin.com/business/talent/blog/talent-strategy/linkedin-most-in-demand-hard-and-soft-skill


